Article info
PDFResearch ethics
Paper
Improving access to medicines: empowering patients in the quest to improve treatment for rare lethal diseases
- Correspondence to Professor Paul Talman, Neurosciences Department, Barwon Health, The Geelong Hospital, Ryrie Street Geelong, Victoria 3220, Australia; pault{at}barwonhealth.org.au
Citation
Improving access to medicines: empowering patients in the quest to improve treatment for rare lethal diseases
Publication history
- Received February 14, 2013
- Revised May 27, 2013
- Accepted May 28, 2013
- First published July 9, 2013.
Online issue publication
November 24, 2015
Article Versions
- Previous version (9 July 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Tragic choices
- Using telehealth in motor neuron disease to increase access to specialist multidisciplinary care: a UK-based pilot and feasibility study
- Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial)
- Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
- Epidemiology of ALS in Korea using nationwide big data
- Amyotrophic lateral sclerosis and the innate immune system: protocol for establishing a biobank and statistical analysis plan
- Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China
- A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland
- The management of motor neurone disease
- Pathophysiological insights into ALS with C9ORF72 expansions